Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden

被引：3
|
作者：
Smedby, Karin Ekstrom Ekstroem [1 ,2 ]
Ekberg, Sara [2 ]
Eloranta, Sandra [2 ]
Enblad, Gunilla [3 ]
Jerkeman, Mats [4 ]
Andersson, Per-Ola
Harrysson, Sara [2 ,5 ]
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Karolinska Inst, Div Clin Epidemiol, Dept Med Solna, Stockholm, Sweden
[3] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[4] Lund Univ, Inst Clin Sci, Dept Pathol & Oncol, Lund, Sweden
[5] Karolinska Univ Hosp, Dept Hematol, Solna, Sweden
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123785
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4111
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Jerkeman, Mats
    Hasselblom, Sverker
    Wahlin, Bjorn E.
    Andersson, Per-Ola
    Smedby, Karin E.
    BLOOD, 2018, 132
  • [2] Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
    Sara Harrysson
    Sandra Eloranta
    Sara Ekberg
    Gunilla Enblad
    Mats Jerkeman
    Bjorn E. Wahlin
    Per-Ola Andersson
    Karin E. Smedby
    Blood Cancer Journal, 11
  • [3] Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Jerkeman, Mats
    Hasselblom, Sverker
    Wahlin, Bjorn E.
    Andersson, Per-Ola
    Smedby, Karin E.
    BLOOD, 2019, 134
  • [4] Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Jerkeman, Mats
    Wahlin, Bjorn E.
    Andersson, Per-Ola
    Smedby, Karin E.
    BLOOD CANCER JOURNAL, 2021, 11 (01)
  • [5] Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context
    Abdulhaq, Haifaa
    Hwang, Andrew
    Mahmood, Omar
    ONCOTARGETS AND THERAPY, 2023, 16 : 617 - 629
  • [6] Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study
    Arboe, Bente
    Olsen, Maja Halgren
    Gorlov, Jette Sonderskov
    Duun-Henriksen, Anne Katrine
    Dalton, Susanne Oksbjerg
    Johansen, Christoffer
    Brown, Peter de Nully
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 207 - 216
  • [7] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [8] Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Salles, Gilles
    Dlugosz-Danecka, Monika
    Ghesquieres, Herve
    Jurczak, Wojciech
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 455 - 463
  • [9] Tafasitamab for the Treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the US Real-World Setting
    Saverno, Kimberly
    Savill, Kristin M. Zimmerman
    Feinberg, Bruce
    Galvin, John
    Pathak, Prathamesh
    Gordon, Sarah
    Amoloja, Theresa
    Llorente, Mae
    Epperla, Narendranath
    Nastoupil, Loretta J.
    BLOOD, 2023, 142
  • [10] Prescriber Preference in Treatment of Relapsed or Refractory Multiple Myeloma (MM) and Diffuse Large B-Cell Lymphoma (DLBCL)
    Gupta, Supriya
    Ng, Lay She
    Munoz, Javier L.
    Bennani, N. Nora
    Khurana, Arushi
    Paludo, Jonas
    Cook, Joselle
    Kourelis, Taxiarchis
    Abdallah, Nadine
    Bisneto, Jose C. Villasboas
    Wang, Yucai
    Hampel, Paul J.
    Gertz, Morie A.
    Warsame, Rahma M.
    Hayman, Suzanne R.
    Iqbal, Madiha
    Leung, Nelson
    Kapoor, Prashant
    Kumar, Shaji
    Dingli, David
    Johnston, Patrick B.
    Ansell, Stephen M.
    Lin, Yi
    Durani, Urshila
    BLOOD, 2024, 144 : 7589 - 7590
12345